Swiss big pharma Roche has agreed to license ZW209, an experimental cancer immunotherapy from Vancouver-based Zymeworks, for ...
Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results